Seppo Ylä‐Herttuala
Impact in
- Biochemistry top 0.02%
- Antioxidant Activity and Oxidative Stress
- Oncology top 0.1%
- Lymphatic System and Diseases
Papers in
-
- Angiogenesis and VEGF in Cancer 124
- RNA Interference and Gene Delivery 58
- Viral Infectious Diseases and Gene Expression in Insects 56
- CRISPR and Genetic Engineering 51
- Genetics 178
- Virus-based gene therapy research 164
- Co-authors
- Kari K. Alitalo (78 shared papers)Wulf Palinski (10 shared papers)Joseph Lee Witztum (10 shared papers)Michael E. Rosenfeld (10 shared papers)Daniel Howard Steinberg (8 shared papers)Tuomas T. Rissanen (44 shared papers)Thomas E. Carew (3 shared papers)Jukka S. Luoma (30 shared papers)
- Journals
- Molecular Therapy (40 papers)Atherosclerosis (39 papers)Gene Therapy (31 papers)Human Gene Therapy (30 papers)Arteriosclerosis Thrombosis and Vascular Biology (26 papers)
- Partner nations
- FinlandUnited StatesSweden
In The Last Decade
Seppo Ylä‐Herttuala
789 papers receiving 50.5k citations
Seppo Ylä‐Herttuala's Hit Papers
Peers
Comparison fields: 5 of 185
- Biochemistry 4.0k
- Oncology 10.5k
- Immunology 8.3k
- Molecular Biology 22.9k
- Cancer Research 4.6k
Countries citing papers authored by Seppo Ylä‐Herttuala
This map shows the geographic impact of Seppo Ylä‐Herttuala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seppo Ylä‐Herttuala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seppo Ylä‐Herttuala more than expected).
Fields of papers citing papers by Seppo Ylä‐Herttuala
This network shows the impact of papers produced by Seppo Ylä‐Herttuala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seppo Ylä‐Herttuala. The network helps show where Seppo Ylä‐Herttuala may publish in the future.
Co-authors
The 25 scholars most cited alongside Seppo Ylä‐Herttuala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 805 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. Hit paper breakdown → | 1989 | 1686 |
| 2 | Low density lipoprotein undergoes oxidative modification in vivo. Hit paper breakdown → | 1989 | 1346 |
| 3 | Autoantibody against oxidised LDL and progression of carotid atherosclerosis Hit paper breakdown → | 1992 | 1151 |
| 4 | Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Hit paper breakdown → | 1991 | 796 |
| 5 | Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation Hit paper breakdown → | 2008 | 677 |
| 6 | 2001 | 649 | |
| 7 | 1990 | 562 | |
| 8 | Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. | 2001 | 551 |
| 9 | Consensus guidelines for the use and interpretation of angiogenesis assays Hit paper breakdown → | 2018 | 504 |
| 10 | 2001 | 496 | |
| 11 | 2005 | 487 | |
| 12 | 2005 | 474 | |
| 13 | History of gene therapy Hit paper breakdown → | 2013 | 472 |
| 14 | 1994 | 470 | |
| 15 | 2004 | 465 | |
| 16 | 1995 | 463 | |
| 17 | 2008 | 459 | |
| 18 | 2006 | 445 | |
| 19 | 1990 | 435 | |
| 20 | 2002 | 433 |
About Seppo Ylä‐Herttuala
Seppo Ylä‐Herttuala is a scholar working on Molecular Biology, Genetics, Oncology, Immunology and Cancer Research, having authored 805 papers that have together received 52.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (164 papers), Angiogenesis and VEGF in Cancer (124 papers), Atherosclerosis and Cardiovascular Diseases (74 papers), Lymphatic System and Diseases (70 papers), RNA Interference and Gene Delivery (58 papers), Viral Infectious Diseases and Gene Expression in Insects (56 papers), CAR-T cell therapy research (52 papers) and CRISPR and Genetic Engineering (51 papers). The work is most often cited by research in Biochemistry (4.0k citations), Oncology (10.5k citations), Immunology (8.3k citations), Molecular Biology (22.9k citations) and Cancer Research (4.6k citations). Seppo Ylä‐Herttuala has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Kari K. Alitalo, Wulf Palinski, Joseph Lee Witztum, Michael E. Rosenfeld, Daniel Howard Steinberg, Tuomas T. Rissanen, Thomas E. Carew, Jukka S. Luoma, Sampath Parthasarathy and Mikko P. Turunen. Their work appears in journals such as Molecular Therapy, Atherosclerosis, Gene Therapy, Human Gene Therapy and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.